Abstract
Background
Patients with hypertrophic cardiomyopathy may develop symptoms of shortness of breathing due to diastolic dysfunction which is not related to the severity of left ventricular outflow tract obstruction. As these patients usually develop a non-ischemic pattern of myocardial fibrosis, this may represent a mechanism for increased myocardial stiffness leading to impaired diastolic filling. The study aimed to determine the prevalence of myocardial fibrosis assessed by magnetic resonance imaging in children with hypertrophic cardiomyopathy and to evaluate its relationship with echocardiographic parameters including left ventricle diastolic dysfunction and to find echocardiographic indices which correlates with myocardial fibrosis as detected by cardiac magnetic resonance. A cross-sectional study was done for data of 50 children with hypertrophic cardiomyopathy from July 2018 to July 2021, patients were divided into (group 1) having myocardial fibrosis and (group 2) with no myocardial fibrosis, and results of echocardiographic parameters were compared between the two groups.
Results
Results showed strong relationship between presence of myocardial fibrosis and each of the following: Interventricular septum thickness, lower lateral and septal early diastolic tissue velocities (E′), E/E′ ratio, presence of left ventricular out flow tract obstruction and the grade of diastolic dysfunction.
Conclusions
The trans-mitral lateral and septal E/E′ (early mitral inflow to early diastolic mitral annular velocity ratio) allows early detection of left ventricular diastolic dysfunction in children with hypertrophic cardiomyopathy. The prevalence of diastolic dysfunction is higher in obstructive hypertrophic cardiomyopathy. The diastolic dysfunction severity is higher in patients with myocardial fibrosis.
Similar content being viewed by others
Explore related subjects
Find the latest articles, discoveries, and news in related topics.Background
Hypertrophic cardiomyopathy (HCM) is a relatively common genetic cardiac disease, accounting for 42% of childhood cardiomyopathy [1]. The severity of cardiac hypertrophy, etiology, as well as the clinical course of hypertrophic cardiomyopathy (HCM) in children, is varied, resulting in a large spectrum of clinical and phenotypic expression [2, 3]. Many patients develop symptoms of breathlessness due to diastolic dysfunction which is largely independent of the severity of left ventricular outflow tract obstruction (LVOTO) [4]. As patients with hypertrophic cardiomyopathy (HCM) frequently demonstrate a non-ischemic pattern of myocardial fibrosis, this may represent a mechanism for increased myocardial stiffness leading to impaired diastolic filling [5]. Magnetic resonance imaging (MRI) with late gadolinium enhancement (LGE) can detect a small and focal myocardial fibrosis [6].
Magnetic resonance imaging has been widely accepted for detection of myocardial fibrosis, which has been implicated as a factor in cardiovascular events and left ventricular (LV) function [7]. Echocardiographic modalities such as tissue Doppler imaging (TDI) have become a sensitive measure of diastolic ventricular dysfunction. They are relatively load independent and can reliably determine the degree of left ventricular diastolic dysfunction, which affects the clinical course in children with hypertrophic cardiomyopathy (HCM) [8].
Aim of the study
The aim of this study is to determine the diastolic dysfunction in children having hypertrophic cardiomyopathy (HCM) by echocardiography modalities and to evaluate its relationship with prevalence of myocardial fibrosis as detected by cardiac magnetic resonance imaging and if possible to find echocardiographic indices which correlates with myocardial fibrosis as detected by cardiac magnetic resonance (CMR).
Methods
The current study is a cross-sectional study which was done for data of 50 patients with hypertrophic cardiomyopathy (HCM) in pediatric age group (below age of 18 years). All cases were evaluated at Aswan Heart Centre, Aswan, Egypt.
Background and demographic characteristics
Inclusion criteria: Age group: below age of 18 years, both sexes, echocardiographic evidence of myocardial hypertrophy defined as a diastolic septal thickness or left ventricular diastolic wall thickness z-score > 2. The MRI and echocardiography were done during the same visit.
Exclusion criteria: Presence of hemodynamic conditions that could account for the observed hypertrophy (as systemic hypertension), presence of congenital anomalies resulting in pressure overload against left ventricle (as congenital aortic stenosis or coarctation of aorta). Atrial fibrillation also was one of the exclusion criteria.
All patients were subjected to:
-
1.
Full history taking focusing on patient demographics: age, sex, weight, height & body surface area, clinical symptoms of heart failure or low cardiac output (dyspnea on exertion, dizziness, syncope, chest pain), family history of hypertrophic cardiomyopathy (HCM), family history of sudden cardiac death (SCD) defined as one or more cardiac death in first-degree relatives of < 40 years of age with or without a diagnosis of hypertrophic cardiomyopathy (HCM) or sudden cardiac death (SCD) in first-degree relatives with confirmed hypertrophy at any age [9].
-
2.
Echocardiography all echocardiograms were done by echo machine Philips IE33, Two-dimensional ECHO focusing on: Presence of hypertrophic cardiomyopathy was diagnosed when the diastolic septal thickness or left ventricular diastolic wall thickness z-score > 2 in the absence of hemodynamic conditions that could account for the observed LV hypertrophy [9], Left atrial (LA) diameter (mm, z-score) and left atrial volume indexed to body surface area. Presence of left ventricular outflow tract obstruction (LVOTO). Left ventricular outflow tract obstruction (LVOTO) was considered present when a peak outflow gradient of ≥ 30 mm Hg with continuous-wave Doppler echocardiography. Assessment of mitral regurgitation severity, according to relation of regurgitant area to left atrium area (< 15% is mild, 15–50% is moderate, > 50% is severe) [10]. Assessment of tricuspid regurgitation and estimation of the tricuspid regurge velocity by meter/sec. Conventional pulsed Doppler focusing on: mitral inflow pattern at the leaflet tips in the apical 4-chamber view, peak velocities of E (early mitral inflow) and A (late mitral inflow corresponds to atrial contraction) waves (cm/s) and their ratio (E/A) were measured in 3 successive cardiac cycles and average value of each measurement was taken. A wave duration by msec measured in 3 successive cardiac cycles was measured and average value was taken right upper pulmonary vein flow with measurement of atrial reversal flow (AR wave) duration in 3 successive cardiac cycles, and average value was taken (in patients with sinus rhythm). Tissue Doppler imaging (TDI) with breath holding during 3 consecutive cardiac cycles (whenever possible) focusing on: longitudinal annular velocities at the lateral as well as the septal mitral annular points. Early diastolic (E′) and late diastolic (A′) tissue Doppler velocities (cm/s) were measured at the lateral as well as the septal mitral annular points and subsequently averaged over 3 cardiac cycles. Trans-mitral E/E′ ratios (lateral and septal) were calculated for each patient. M-mode echocardiography focusing on septal wall thickness (SWT) and left ventricular posterior wall thickness (LVPWT) (mm, z-score).
Diastolic dysfunction is assessed in patients with hypertrophic cardiomyopathy (HCM) as follows: 4 cut-off values for assessment of diastolic dysfunction are: Average E/E′ ratio > 14, left atrial (LA) volume indexed > 34 ml/m2, Atrial flow reversal (AR-A wave) duration > 30 ms, Peak velocity of tricuspid regurgitation (TR) jet by CW Doppler > 2.8 m/sec. In case of severe mitral regurge only 2 variables are applied which are AR-A duration and peak velocity of tricuspid regurgitation (TR) jet. Presence of more than half of the variables means that left atrial pressure (LAP) is elevated and grade II diastolic dysfunction is diagnosed; if less than half of the variables is present, then left atrial pressure (LAP) is normal and grade I diastolic dysfunction is diagnosed. Grade III diastolic dysfunction is diagnosed in the presence of restrictive filling pattern and abnormally reduced annular E′ velocity (septal < 7 cm/sec, lateral < 10 cm/sec). Absence of any of the variables means that no diastolic dysfunction [11]. Z score calculation was done by the following online calculator: http://parameterz.blogspot.com/2008/09/z-scores-of-cardiac-tructures.html.
-
3.
Cardiac magnetic resonance imaging (CMR) Magnetic resonance imaging was performed on a 1.5 T scanner (Siemens, Germany). Cine images were acquired with steady-state free-precession technique (true FISP; slice thickness 8 mm) in three long-axis planes and contiguous short-axis slices (true FISP; slice thickness 8 mm, 2 mm gap) from the atrioventricular ring to the apex. An intravenous bolus of 0.1 mmol/kg of gadodiamide is given and late gadolinium images were acquired in the same planes after 10 min, with a breath-hold (whenever possible) segmented inversion-recovery sequence (inversion time: 280–400 ms). The presence of left ventricular late gadolinium enhancement (LGE) was determined using visual assessment by two independent observers.
Statistical analysis
The collected data were organized, tabulated, and statistically analyzed using SPSS software statistical computer package version 18 SPSS Inc, USA. For quantitative data, the mean and standard deviation (SD) were calculated. Independent t-test as used in comparing between two groups as regards mean values of different variables. Qualitative data were presented as number and percentages; Chi-square (X2) was used as a test of significance. For interpretation of results of significance, significance was adopted at P < 0.05.
Results
The current study aimed to determine the diastolic dysfunction in children having hypertrophic cardiomyopathy (HCM) by echocardiography modalities and to evaluate its relationship with prevalence of myocardial fibrosis as detected by cardiac magnetic resonance imaging. Based on the MRI findings, children were divided into two groups as follows: Group A: children diagnosed as having hypertrophic cardiomyopathy (HCM) with myocardial fibrosis. Group B: children having hypertrophic cardiomyopathy (HCM) without myocardial fibrosis. The results of echocardiographic parameters regarding presence or absence of diastolic dysfunction and its degree were analyzed and compared between the two groups.
The current study was conducted on 50 patients in pediatric age group with hypertrophic cardiomyopathy (HCM) from July 2018 to July 2021 (Table 1). We aimed to determine the diastolic dysfunction in children having hypertrophic cardiomyopathy (HCM) by echocardiography modalities and to evaluate its relationship with prevalence of myocardial fibrosis as detected by cardiac magnetic resonance imaging (Fig. 1 and 2).
The mean age at Echo was 8.44 years; the mean age at MRI was 8.35 (Table 1). There was no time gap between Echo and MRI, both Echo and MRI were done during the same visit, 72% of cases were males (36 patients) and 28% of patients were females (14 patients). The mean body weight was 25.95 kg, the mean height was 119.71 cm and the mean BSA was 0.92. Our study showed that the mean SWTD Z-score was 5.49, mean LVPWD Z-score was 3.72 and mean left atrial (LA) dimension Z-score was 3.22 (Table 2), although Z-scores of all parameters were high, the thickness was marked in septal wall rather than posterior wall which translates the usual tendency of hypertrophy in hypertrophic cardiomyopathy (HCM) to be asymmetrical (Table 2).
Among the 50 patients of the studied group, 84% of cases had a degree of mitral regurgitation (MR), which was caused mainly by systolic anterior motion (SAM) of mitral valve leaflets, 36% of the studied group had severe mitral regurgitation which affected cut-off points used in evaluation of diastolic dysfunction [11] (Table 3).
Tissue Doppler imaging (TDI) parameters results showed mean values which meet cut-off values for diagnosis of diastolic dysfunction, mean velocity of lateral E` was 8.76 cm/s (cut-off value < 10 cm/s), mean lateral E/E′ was 13.74 (cut-off value > 14), mean medial E` velocity was 6.2 cm/s (cut-off value < 7 cm/s) and mean septal E/E′ was 18.57 (cut-off value > 14) as seen in Table 4. MRI-based presence of myocardial fibrosis was strongly correlated with tissue Doppler velocity indices especially septal E′ and (E/E′) ratio (Table 5).
Studying relationship between myocardial fibrosis and diastolic dysfunction (Table 6) showed very strong relationship between degree of diastolic dysfunction and presence of fibrosis, among cases with myocardial fibrosis all cases have diastolic dysfunction grade 2 or 3, while patients without myocardial fibrosis did not have grade 3 diastolic dysfunction, while among cases with no myocardial fibrosis, prevalence of grade 3 diastolic dysfunction was 0%, which showed how grade of diastolic dysfunction and myocardial fibrosis are strongly linked.
Data showed significant relationship between presence of hypertrophic obstructive cardiomyopathy (HOCM) and diastolic dysfunction (P value ≤ 0.001) (Table 7). Studying relationship between pattern of hypertrophic cardiomyopathy (HCM) and presence of myocardial fibrosis (Table 8) showed that 75% of cases with non-obstructive hypertrophic cardiomyopathy (HCM) were free of myocardial fibrosis, while only 47% of cases with hypertrophic obstructive cardiomyopathy (HOCM) were free of myocardial fibrosis.
Discussion
To our knowledge, this is the youngest population in which diastolic dysfunction was studied in hypertrophic cardiomyopathy (HCM). We found that the percentage of diastolic dysfunction in our study was 84% (Table 3), the percentage is high when compared to Ziolkowska et al. [12] who found that percentage of diastolic dysfunction was 54%, but in their study percentage of HOCM to the studied population was 24%, while in our study percentage of HOCM to studied population was 68%, this can be explained from our study by understanding the relationship between pattern of hypertrophic cardiomyopathy (HCM) and prevalence of diastolic dysfunction, as we found that there is a very strong relationship between diastolic dysfunction and presence of obstructive form of hypertrophic cardiomyopathy (HCM) (P-value = 0.001) which can explain the cause of the large discrepancy between both studies in the prevalence of diastolic dysfunction.
In current study, 44% of the studied group had myocardial fibrosis (22 patients) in comparison with Ziolkowska et al. [12] who found that 60% of studied group had myocardial fibrosis. Putting in consideration that our study population mean age is lower than the previous study by 4 years, this can answer the question why the percentage can differ between both studies. As we found from observations, myocardial fibrosis tends to appear in older age, and it is most probably a progressively ongoing process.
Based on MRI findings, children were classified as either patients with myocardial fibrosis according to MRI (n = 22; 44%) or without fibrosis (n = 28; 56%). In adult patients with hypertrophic cardiomyopathy (HCM), the presence of fibrosis according to MRI correlated with left ventricular (LV) wall thickness and left atrial (LA) size [13, 14]. Similarly, one study was applied on children with hypertrophic cardiomyopathy (HCM) showed that children with myocardial fibrosis had significantly increased septum thickness, a higher left ventricular posterior wall (LVPWT), and significantly larger left atrial (LA) dimension and volume index on echocardiography compared to patients without fibrosis [12], we found similar results in our study as children in the studied group with myocardial fibrosis had a significantly thicker interventricular septum (P ≤ 0.0001), compared to patients without fibrosis (Table 5).
Our results showed that MRI-based presence of myocardial fibrosis was strongly correlated with tissue Doppler velocity indices especially septal E′ and (E/E′) ratio (Table 5), And these results are comparable with previous studies which studied relationship between diastolic dysfunction and myocardial fibrosis [15, 16]. Our results demonstrated that children with myocardial fibrosis in MRI had significantly lower lateral and septal early diastolic tissue velocities (E′) as well as a significantly higher lateral and septal E/E′ ratio compared to patients without fibrosis, Ziolkowska et al. [12] reported similar findings in pediatrics, and Ellims et al. [17] reported similar findings in adults. Studying relationship between myocardial fibrosis and diastolic dysfunction (Table 6) showed very strong relationship between degree of diastolic dysfunction and presence of fibrosis, among cases with myocardial fibrosis all cases have diastolic dysfunction grade 2 or 3, while patients without myocardial fibrosis did not have grade 3 diastolic dysfunction, while among cases with no myocardial fibrosis, prevalence of grade 3 diastolic dysfunction was 0%, which showed how grade of diastolic dysfunction and myocardial fibrosis are strongly linked. These results are comparable with Moreo et al. [16], who found a very strong relationship between degree of diastolic dysfunction and degree of myocardial fibrosis in adults.
Our results showed significant relationship between presence of hypertrophic obstructive cardiomyopathy (HOCM) and diastolic dysfunction, (Table 7). Our data also showed that 75% of cases with non-obstructive hypertrophic cardiomyopathy (HCM) were free of myocardial fibrosis, while only 47% of cases with hypertrophic obstructive cardiomyopathy (HOCM) were free of myocardial fibrosis, (Table 8).
Study limitations
In our study we faced some limitations as studying diastolic dysfunction in young (sedated) or older non co-operative children was difficult as its optimally done with breath holding during 3 consecutive cardiac cycles which is practically difficult. Similarly young (sedated) and older non co-operative patients with latent left ventricular outflow tract obstruction (LVOTO) which isn’t diagnosed by resting Echocardiography were missed as they couldn’t do exercise or Valsalva maneuver. Also there was high risk of anesthesia in patients with both severe left ventricular outflow tract obstruction (LVOTO) and severe right ventricular outflow tract obstruction (RVOTO), and in patients with impaired LV systolic and these patients couldn’t be studied by MRI, and hence were excluded, and being expensive, MRI couldn’t be repeated in minority of cases when its relatively old.
Conclusions
Myocardial fibrosis in children with hypertrophic cardiomyopathy was associated with markers for disease severity such as greater septum thickness and impairment of left ventricular diastolic function. So, the trans-mitral lateral and septal E/E′ (early mitral inflow to early diastolic mitral annular velocity ratio) together with measurement of inter-ventricular septal thickness allow early detection of myocardial fibrosis in children with hypertrophic cardiomyopathy. Echocardiography with tissue Doppler imaging is a feasible and sensitive method for evaluating left ventricular diastolic dysfunction in children with hypertrophic cardiomyopathy and myocardial fibrosis. Pediatric patients with obstructive form of hypertrophic cardiomyopathy have higher incidence (and high grade when present) of diastolic dysfunction that non-obstructive form. Higher degrees of diastolic dysfunction are higher in patients with myocardial fibrosis who always have at least 2nd degree of diastolic dysfunction, while patients without myocardial fibrosis never had grade 3 diastolic dysfunction.
Availability of data and materials
Authors declare availability of data used in the study.
Abbreviations
- HCM:
-
Hypertrophic cardiomyopathy
- LVOTO:
-
Left ventricular outflow tract obstruction.
- MRI:
-
Magnetic resonance imaging
- LGE:
-
Late gadolinium enhancement
- TDI:
-
Tissue Doppler imaging
- CMR:
-
Cardiac magnetic resonance
- SCD:
-
Sudden cardiac death
- AR:
-
Atrial reversal
- SWT:
-
Septal wall thickness
- LVPWT:
-
Left ventricular posterior wall thickness.
- LAP:
-
Left atrial pressure
- LA:
-
Left atrium
- MR:
-
Mitral regurgitation
- SAM:
-
Systolic anterior motion
References
Lipshultz SE, Sleeper LA, Towbin JA et al (2003) The incidence of pediatric cardiomyopathy in two regions of the United States. N Eng J Med 348:1647–1655
Maron BJ (2004) Hypertrophic cardiomyopathy in childhood. Paediatr Clin North Am 51:1305–1334
Nugent A, Daubeney P, Chondros P et al (2005) Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation 112:1332–1338
Fifer MA, Vlahakes GJ (2008) Management of symptoms in hypertrophic cardiomyopathy. Circulation 117:429–439
Varnava AM, Elliott PM, Sharma S, McKenna WJ, Davies MJ (2000) Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84:476–482
Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA (2011) Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57:891–903
O’Hanlon R, Grasso A, Roughton M et al (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56:867–874
Nagueh SF, Bachinski LL, Meyer D et al (2001) Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 104:128–130
Elliott PM, Anastasakis A, Borger MA et al (2014) ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733–79
Apostolakis EE, Baikoussis NG (2009) Methods of estimation of mitral valve regurgitation for the cardiac surgeon. J Cardiothorac Surg 15(4):34
Nagueh SF, Smiseth OA, Appleton CP et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29:277–314
Ziolkowska L, Petryka J, Boruc A, Kawalec W (2017) comparison of echocardiography with tissue Doppler imaging and magnetic resonance imaging with delayed encahncement in assessment of children with hypertrophic cardiomyopathy. Arch Med Sci 13(2):328–336
Rubinshtein R, Glockner JF, Ommen SR et al (2010) Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Cir Heart Fail 3:51–58
Choudhury L, Mahrholdt H, Wagner A et al (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40:2156–2164
Maron MS, Appelbaum E, Harrigan CJ et al (2008) Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail 1:184–191
Moreo A, Ambrosio G, De Chiara B et al (2009) Influence of myocardial fibrosis on left ventricular diastolic function noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging 2:437–443
Ellims AH, Iles LM, Ling LH, Hare JL, Kaye DM, Taylor AJ (2012) Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Reson 14:64–76
Acknowledgements
Not applicable.
Funding
The authors declare that no funding was received for conducting this study.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Initial plan and study design were made by SA and SD. Performing Echo and clinical examination were by SD and OE. Material preparation, data collection and analysis were performed by OE and RA. The first draft of the manuscript was written by OE and SD. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The authors declare review and approval of the study by Aswan Heart Centre as well as faculty of medicine, Fayoum university research ethical committees. Freely given, informed, written consent to participate in the study was obtained from participants parents. Participants were informed about the objectives of the study. Committee’s reference number: not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Deraz, S.E., Esmat, O.D., El-Hmid, R.G.A. et al. Evaluation of diastolic dysfunction in children with hypertrophic cardiomyopathy and its relationship with development of myocardial fibrosis. Egypt Heart J 75, 54 (2023). https://doi.org/10.1186/s43044-023-00382-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s43044-023-00382-1